Literature DB >> 1751488

Reconstitution of catalytically competent human zeta-thrombin by combination of zeta-thrombin residues A1-36 and B1-148 and an Escherichia coli expressed polypeptide corresponding to zeta-thrombin residues B149-259.

Z R Gan1, S D Lewis, J R Stone, J A Shafer.   

Abstract

Human zeta-thrombin, a catalytically competent serine proteinase, arises from a single chymotryptic cleavage at Trp-148 in alpha-thrombin to generate two nonconvalently associated polypeptide segments designated zeta 1-thrombin (the 36-residue A-chain disulfide linked to B-chain residues B1-148) and zeta 2-thrombin (B149-259). We report here the expression of recombinant zeta 2-thrombin in Escherichia coli and the reconstitution of catalytically competent zeta-thrombin by combination of zeta 1-thrombin with recombinant zeta 2-thrombin. A DNA fragment encoding zeta 2-thrombin was cloned into a pATH2 expression vector as a trpE-zeta 2 fusion gene, in which a factor Xa cleavage site was inserted between the trpE and the zeta 2-thrombin gene. High-level expression of this fusion protein was achieved under the control of the E. coli trp promoter. The expressed zeta 2-thrombin was liberated from the fusion protein by factor Xa cleavage, reduced with DTT, and purified to homogeneity by reverse-phase HPLC. Oxidation of the reduced zeta 2-thrombin in the presence of 80 microM CuSO4 and 6 M urea at pH 8.15 yielded material that was indistinguishable on HPLC from zeta 2-thrombin isolated by resolution of human zeta-thrombin. Catalytically active zeta-thrombin was generated by combination of recombinant zeta 2-thrombin with zeta 1-thrombin that was isolated by resolution of human zeta-thrombin. Recombinant zeta-thrombin displayed catalytic activities, toward a small chromogenic substrate and fibrinogen, that were similar to those of alpha-thrombin prepared from human blood plasma and zeta-thrombin obtained by treatment of alpha-thrombin with chymotrypsin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1751488     DOI: 10.1021/bi00114a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Fragment complementation of calbindin D28k.

Authors:  T Berggård; E Thulin; K S Akerfeldt; S Linse
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

2.  In vivo protein stabilization based on fragment complementation and a split GFP system.

Authors:  Stina Lindman; Armando Hernandez-Garcia; Olga Szczepankiewicz; Birgitta Frohm; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 3.  Thrombin domains: structure, function and interaction with platelet receptors.

Authors:  Raimondo De Cristofaro; Erica De Candia
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

4.  Catalytically competent human and bovine zeta-thrombin and chimeras generated from unfolded polypeptide chains.

Authors:  S D Lewis; D V Brezniak; J W Fenton; J A Shafer
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

5.  Human-Phosphate-Binding-Protein inhibits HIV-1 gene transcription and replication.

Authors:  Thomas Cherrier; Mikael Elias; Alicia Jeudy; Guillaume Gotthard; Valentin Le Douce; Houda Hallay; Patrick Masson; Andrea Janossy; Ermanno Candolfi; Olivier Rohr; Eric Chabrière; Christian Schwartz
Journal:  Virol J       Date:  2011-07-15       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.